245 related articles for article (PubMed ID: 22198266)
1. Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.
Prigge JR; Eriksson S; Iverson SV; Meade TA; Capecchi MR; Arnér ES; Schmidt EE
Free Radic Biol Med; 2012 Feb; 52(4):803-10. PubMed ID: 22198266
[TBL] [Abstract][Full Text] [Related]
2. A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification.
Iverson SV; Eriksson S; Xu J; Prigge JR; Talago EA; Meade TA; Meade ES; Capecchi MR; Arnér ES; Schmidt EE
Free Radic Biol Med; 2013 Oct; 63():369-80. PubMed ID: 23743293
[TBL] [Abstract][Full Text] [Related]
3. Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration.
Rollins MF; van der Heide DM; Weisend CM; Kundert JA; Comstock KM; Suvorova ES; Capecchi MR; Merrill GF; Schmidt EE
J Cell Sci; 2010 Jul; 123(Pt 14):2402-12. PubMed ID: 20571049
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.
Prigge JR; Coppo L; Martin SS; Ogata F; Miller CG; Bruschwein MD; Orlicky DJ; Shearn CT; Kundert JA; Lytchier J; Herr AE; Mattsson Å; Taylor MP; Gustafsson TN; Arnér ESJ; Holmgren A; Schmidt EE
Cell Rep; 2017 Jun; 19(13):2771-2781. PubMed ID: 28658624
[TBL] [Abstract][Full Text] [Related]
5. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
6. A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems.
Dóka É; Pader I; Bíró A; Johansson K; Cheng Q; Ballagó K; Prigge JR; Pastor-Flores D; Dick TP; Schmidt EE; Arnér ES; Nagy P
Sci Adv; 2016 Jan; 2(1):e1500968. PubMed ID: 26844296
[TBL] [Abstract][Full Text] [Related]
7. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.
Mandal PK; Schneider M; Kölle P; Kuhlencordt P; Förster H; Beck H; Bornkamm GW; Conrad M
Cancer Res; 2010 Nov; 70(22):9505-14. PubMed ID: 21045148
[TBL] [Abstract][Full Text] [Related]
8. Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption.
Lopert P; Patel M
Redox Biol; 2014; 2():667-72. PubMed ID: 24936441
[TBL] [Abstract][Full Text] [Related]
9. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
Du Y; Zhang H; Lu J; Holmgren A
J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
[TBL] [Abstract][Full Text] [Related]
10. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.
Ekström L; Johansson M; Monostory K; Rundlöf AK; Arnér ES; Björkhem-Bergman L
Biochem Biophys Res Commun; 2013 Jan; 430(1):90-4. PubMed ID: 23154180
[TBL] [Abstract][Full Text] [Related]
12. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse.
Jurado J; Prieto-Alamo MJ; Madrid-Rísquez J; Pueyo C
J Biol Chem; 2003 Nov; 278(46):45546-54. PubMed ID: 12954614
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin/thioredoxin reductase system involvement in cerebellar granule cell apoptosis.
Bobba A; Casalino E; Petragallo VA; Atlante A
Apoptosis; 2014 Oct; 19(10):1497-508. PubMed ID: 25055978
[TBL] [Abstract][Full Text] [Related]
14. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy.
McLoughlin MR; Orlicky DJ; Prigge JR; Krishna P; Talago EA; Cavigli IR; Eriksson S; Miller CG; Kundert JA; Sayin VI; Sabol RA; Heinemann J; Brandenberger LO; Iverson SV; Bothner B; Papagiannakopoulos T; Shearn CT; Arnér ESJ; Schmidt EE
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11408-11417. PubMed ID: 31097586
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress.
Park WH
Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420
[TBL] [Abstract][Full Text] [Related]
16. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration.
Carlson BA; Tobe R; Yefremova E; Tsuji PA; Hoffmann VJ; Schweizer U; Gladyshev VN; Hatfield DL; Conrad M
Redox Biol; 2016 Oct; 9():22-31. PubMed ID: 27262435
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems.
Go YM; Roede JR; Walker DI; Duong DM; Seyfried NT; Orr M; Liang Y; Pennell KD; Jones DP
Mol Cell Proteomics; 2013 Nov; 12(11):3285-96. PubMed ID: 23946468
[TBL] [Abstract][Full Text] [Related]
18. Thiol-metabolizing proteins and endothelial redox state: differential modulation of eNOS and biopterin pathways.
Sugiyama T; Michel T
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H194-201. PubMed ID: 19897710
[TBL] [Abstract][Full Text] [Related]
19. The A to Z of modulated cell patterning by mammalian thioredoxin reductases.
Dagnell M; Schmidt EE; Arnér ESJ
Free Radic Biol Med; 2018 Feb; 115():484-496. PubMed ID: 29278740
[TBL] [Abstract][Full Text] [Related]
20. Methylglyoxal, the foe and friend of glyoxalase and Trx/TrxR systems in HT22 nerve cells.
Dafre AL; Goldberg J; Wang T; Spiegel DA; Maher P
Free Radic Biol Med; 2015 Dec; 89():8-19. PubMed ID: 26165190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
